Worms reveal new role for hormones in Bardet-Biedl syndrome

December 13, 2011

A new study, conducted by researchers at the University of California, San Francisco, has shed new light on a genetic disease known as Bardet-Biedl syndrome (BBS)--a condition in which patients show mental and developmental delays, short stature, early onset blindness, extra digits on the hands and feet, kidney abnormalities and obesity. While the occurrence of BBS is rare--occurring in roughly 1 in every 150,000 live births--scientists believe that by understanding the mechanisms of function of BBS genes and their protein products they will gain insights into molecular processes that control development, vision, kidney function and obesity.

Following the identification of mutations that cause BBS, scientists had discovered that a set of these genes encode for a protein complex that is required for the proper functioning of cilia, antenna-like structures found on the surfaces of many cells. Like antennae, cilia are important for communication between cells as many proteins that facilitate cell-cell communication signals are localized to these structures.

In the new article, published December 13 in the online, open-access journal PLoS Biology, UCSF researchers report their discovery that mutations in BBS genes not only control incoming communication via the antenna-like cilia but also outgoing communication via the release of hormones. The researchers--led by Dr. Kaveh Ashrafi, associate professor in the UCSF Department of Physiology and a member of UCSF Cardiovascular Research Institute and the Diabetes Center--took advantage of the fact that counterparts of BBS genes are also found in the small roundworm Caenorhabditis elegans. Despite the obvious differences between these microscopic worms and humans, numerous basic mechanisms that underlie cellular and animal physiology work in similar ways in these evolutionarily distant organisms.

Reminiscent of some of the symptoms seen in BBS patients, the mutations in the corresponding C. elegans genes lead to smaller size, abnormal feeding behavior & metabolism, and sensory defects. In the course of analyzing bbs mutant C. elegans, the researchers made an unexpected finding that these mutant animals have abnormally high levels of hormonal release. By blocking this excess release in the bbs worms, but without correcting defects in the cilia, the UCSF researchers found that they could restore normal body size, feeding, and metabolism to the worm.

"Good communication is key to any relationship, and cells are no exception," said Dr. Ashrafi. "This work expands understanding of molecular roles of BBS proteins and suggests that excessive hormonal release could underlie some of the symptoms seen in BBS patients, and thus opens up therapeutic avenues. Of course, we are a long way from knowing that for sure in human. While it is natural to consider all of the complexities of human physiology, it is precisely the simplicity of C. elegans and its amenability to experimentation that is helping us to learn the basic functions of some human disease genes."
-end-
Funding: B.H.L. is supported by NIH Institutional NRSA #5T32HL007731. This work was supported by grants from the Kinship Foundation Searle Scholar's Award, The Burroughs Welcome Career Award, The PBBR program at UCSF, and NIH R01 (DK070149) awards to K.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Citation: Lee BH, Liu J, Wong D, Srinivasan S, Ashrafi K (2011) Hyperactive Neuroendocrine Secretion Causes Size, Feeding, and Metabolic Defects of C. elegans Bardet-Biedl Syndrome Mutants. PLoS Biol 9(12): e1001219. doi:10.1371/journal.pbio.1001219

CONTACT:
Dr Kaveh Ashrafi
Department of Physiology and the UCSF Diabetes Center
University of California San Francisco
N412C Genentech Hall
600 16th St.
San Francisco, CA
94158-2257
Tel: 415-514-4102
kaveh.ashrafi@ucsf.edu

PLOS

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.